ThirdLaw Molecular Rebrands as Ladder Bio; Announces $5.5M Seed Financing Led by Medical Excellence Capital and Appoints Eric Heil as Chief Executive Officer
Industry veterans David Scheer and Brian Halak join Board of Directors PHILADELPHIA–(BUSINESS WIRE)–ThirdLaw Molecular, Inc. today announced its new name change, Ladder Bio Inc., reflecting the company’s mission to pioneer Spiroligomer™ therapeutics (“ladder-shaped peptide-like molecules”),…